TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.

Ciesielska A, Matyjek M, Kwiatkowska K. · 2021

Read TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. by Ciesielska A, Matyjek M, Kwiatkowska K. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7904555.txt.

Introduction

Ciesielska and co-authors present a review of how the immune sensor TLR4 moves inside cells. TLR4 detects lipopolysaccharide, a part of Gram-negative bacteria. Once triggered, it sets off inflammation. A partner protein, CD14, guides the sensor's path. The review traces that journey step by step.

The first wave of signalling starts at the cell surface. The sensor is then pulled inside, where a second wave begins. The inside route is shut down as the sensor is broken down or sent back to the surface. The speed of each step sets the strength and length of the response. When traffic goes wrong, the fallout can feed inherited disease, brain degeneration, autoimmunity, and cancer. The review gathers the proteins that run this traffic into one account.

Catalog record

CREATORCiesielska A, Matyjek M, Kwiatkowska K.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE150 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7904555

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling By Anna Ciesielska, Marta Matyjek, Katarzyna Kwiatkowska Published in: Cellular and Molecular Life Sciences: CMLS DOI: 10.1007/s00018-020-03656-y ABSTRACT Toll-like receptor (TLR) 4 belongs to the TLR family of receptors inducing pro-inflammatory responses to invading pathogens. TLR4 is activated by lipopolysaccharide (LPS, endotoxin) of Gram-negative bacteria and sequentially triggers two signaling cascades: the first one involving TIRAP and MyD88 adaptor proteins is induced in the plasma membrane, whereas the second engaging adaptor proteins TRAM and TRIF begins in early endosomes after endocytosis of the receptor. The LPS-induced internalization of TLR4 and hence also the activation of the TRIF-dependent pathway is governed by a GPI-anchored protein, CD14. The endocytosis of TLR4 terminates the MyD88-dependent signaling, while the following endosome maturation and lysosomal degradation of TLR4 determine the duration and magnitude of the TRIF-dependent one. Alternatively, TLR4 may return to the plasma membrane, which process is still poorly understood. Therefore, the course of the LPS-induced pro-inflammatory responses depends strictly on the rates of TLR4 endocytosis and trafficking through the endo-lysosomal compartment. Notably, prolonged activation of TLR4 is linked with several hereditary human diseases, neurodegeneration and also with autoimmune diseases and cancer. Recent studies have provided ample data on the role of diverse proteins regulating the functions of early, late, and recycling endosomes in the TLR4-induced inflammation caused by LPS or phagocytosis of E. coli. In this review, we focus on the mechanisms of the internalization and intracellular trafficking of TLR4 and CD14, and also of LPS, in immune cells and discuss how dysregulation of the endo-lysosomal compartment contributes to the development of diverse human diseases. INTRODUCTION The mammalian family of Toll-like receptors (TLR) consists of thirteen members with TLR4 being the most extensively studied one. TLRs are representatives of pattern recognition receptors (PRR), so named for their ability to recognize evolutionarily conserved components of microorganisms, including bacteria, viruses, fungi and parasites, collectively called pathogen-associated molecular patterns (PAMPs). The recognition of a PAMP by a PRR triggers rapid inflammatory reactions essential for the innate immunity, as discussed in several previous exhaustive reviews [1–5]. TLR4 is activated by lipopolysaccharide (LPS, endotoxin), a major component of the outer membrane of Gram-negative bacteria. During infection, TLR4 responds to the LPS present in tissues and the bloodstream and triggers pro-inflammatory reactions facilitating eradication of the invading bacteria [6]. It has been indicated that TLR4 can also be activated by endogenous compounds called damage-associated molecular patterns (DAMPs), including high mobility group box protein 1 (HMGB1) and hyaluronic acid. These compounds are released during tissue injury and can activate TLR4 in non-infectious conditions to induce tissue repair [7, 8]. Altogether, apart from LPS and its derivatives, up to 30 naturally occurring agonists of TLR4 with various chemical structures have been postulated. However, only three of them, Ni2+, the plant secondary metabolite paclitaxel, and disulfide HMGB1 have been demonstrated to be direct activators of TLR4, while the others can act as chaperones for TLR4 or promoters of LPS internalization [7, 9, 10]. Nevertheless, the impact of endogenous DAMPs on the TLR4 activity broadens the spectrum of pathophysiological conditions involving the TLR4-induced pro-inflammatory responses far beyond infectious diseases. TLR4 binds LPS with the help of LPS-binding protein (LBP) and CD14, and an indispensable contribution of the MD-2 protein stably associated with the extracellular fragment of the receptor (Fig. 1). The requirement for MD-2 for TLR4 activation by LPS was established shortly after the identification of TLR4 as the LPS receptor, since virtually no responses to LPS were detected in macrophages derived from MD-2−/− mice [11, 12]. The binding of an LPS molecule to the TLR4/MD-2 complex involves acyl chains and phosphate groups of lipid A, the conserved part of LPS and the main inducer of pro-inflammatory responses to LPS [13, 14]. Hexa-acylated and diphosphorylated LPS, like Escherichia coli LPS (O111:B4), is one of the most potent agonists of TLR4 whereas under-acylated LPS and dephosphorylated LPS species have a weaker pro-inflammatory activity especially in human cells [15]. Structural determinants of this phenomenon are found in the TLR4/MD-2 complex and also in CD14 protein [13, 16], as discussed in the following sections.Fig. 1Pro-inflammatory signaling pathways of TLR4. TLR4 activates the MyD88-signaling pathway at the plasma membrane and after a CD14-dependent endocytosis initiates the TRIF-dependent cascade. Via activated NF-κB TLR4 also contributes to the activation of the cytosolic NLRP3 inflammasome. See text for details Under-acylated and dephosphorylated LPS is synthesized by commensal bacteria which colonize human intestines, like Bacteroides thetaiotaomicron, which evade recognition by PRR [17] and are crucial for the maintenance of the intestinal immune balance [15]. In addition, the impermeability of the intestine epithelium to LPS is an important factor preventing its egress into the bloodstream [18]. On the other hand, during infection, deacylation and dephosphorylation of bacterial LPS is important for the termination of inflammatory responses, as discussed in detail below in the section concerning LPS detoxification. An exaggerated and uncontrolled pro-inflammatory signaling triggered by TLR4 during infection can lead to sepsis, septic shock, and death [19]. Infections with Gram-negative bacteria, including E. coli and Pseudomonas aeruginosa, are the prevailing cause of severe sepsis in humans [20]. In addition, low doses of LPS derived from the gut microbiota can in certain conditions enter the bloodstream and evoke so-called metabolic endotoxemia leading to a chronic low-grade TLR4-dependent inflammation which contributes to the development of metabolic diseases, such as type 2 diabetes [18, 21–23]. Prolonged activation of TLR4 is also linked with several human hereditary and neurodegenerative diseases and also with autoimmune diseases and cancer [24, 25]. On the other hand, an experimental exclusion of TLR4-triggered signaling during low-grade polymicrobial sepsis resulted in an impaired bacterial clearance and thereby worsened organ injury leading to a higher mortality of mice [26, 27]. Thus, the cellular level of TLR4 and its signaling activity have to be tightly regulated to be beneficial rather than harmful to the host. TLR4 is expressed in immune cells mainly of myeloid origin, including monocytes, macrophages and dendritic cells (DC), and also in some non-immune cells, like endothelial cells [28]. Most myeloid cells express also high amounts of plasma membrane-anchored CD14 [29, 30], which facilitates the activation of TLR4 by LPS and controls the subsequent internalization of the LPS-activated TLR4 important for receptor signaling and degradation. With the help of CD14, TLR4, unlike all the other TLRs, triggers two signaling pathways called the MyD88-dependent and the TRIF-dependent one after the adaptor proteins involved in their induction [31–34]. These signaling pathways lead to the production of two sets of pro-inflammatory cytokines which only partially overlap [35–39]. The MyD88- and TRIF-dependent signaling pathways are triggered consecutively and linked with the redistribution of the LPS-activated TLR4 from the plasma membrane to endosomes [40]. The translocation of TLR4 to the cell interior and its further lysosomal degradation facilitate termination of the inflammatory response [41]. In this review, we discuss the mechanisms of the internalization and intracellular trafficking of TLR4 and CD14, and also of LPS in immune cells. We emphasize the mechanisms regulating the trafficking of TLR4 and CD14 and thereby affecting the TLR4-induced pro-inflammatory signaling, its magnitude, duration and eventually also TLR4 degradation. Finally, we discuss data pointing to how disturbances in those processes

Read the complete text